PRLD
Prelude Therapeutics Incorporated ยท ยท NASDAQ
$4.25
โผ $0.07 (โ1.62%)
Market cap
$344.1M
52-week range
$0.75 โ $5.54
Volume
3K
Previous close
$4.32
Prelude Therapeutics Incorporated (PRLD) is held by 2 tracked hedge fund(s). Largest tracked holder: ORBIMED ADVISORS LLC.
| Fund | % of portfolio | Shares | Value | Latest activity | Avg buy price | Date |
|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC ORBIMED ADVISORS LLC |
0.7% | 10.9M | $37M | โ | $5.70 | 2026-03-31 |
| BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP |
0.2% | 10.1M | $35M | โ | $5.70 | 2026-03-31 |
FAQ โพ
Which hedge funds hold PRLD?
Tracked holders include: ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP.
How much smart money owns PRLD?
2 tracked hedge fund(s) have disclosed positions.
Are members of Congress trading PRLD?
No tracked Congressional trades in PRLD on file.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings ยท Not investment advice โพ
Ownership from SEC filings; price from market data.
Published by WealthFile ยท Not investment advice.